Compositions methods and systems for pulmonary delivery of recombinant human interferon alpha-2b
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Dec 14, 2004
Grant Date -
Dec 4, 2003
app pub date -
May 31, 2002
filing date -
May 31, 2002
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
Stable aqueous formulations which are free of products derived from human or animal origin and which maintain high biological activity and high chemical and physical stability of alpha-type interferon for an extended period of time. Methods of producing stable aerosol formulations of the same for delivery to the lungs are also provided, as well as systems and methods of delivering the formulations to the lungs for systemic absorption.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully